| 2019年南非《利福平耐药结核病管理临床指南》解读及与我国《耐药结核病化学治疗指南(2019年)》对比 |
| |
| 引用本文： | 冯莹,任斐. 2019年南非《利福平耐药结核病管理临床指南》解读及与我国《耐药结核病化学治疗指南(2019年)》对比[J]. 中国防痨杂志, 2021, 43(3): 295-298. DOI: 10.3969/j.issn.1000-6621.2021.03.018 |
| |
| 作者姓名： | 冯莹 任斐 |
| |
| 作者单位： | 710100.西安市胸科医院耐药结核科 |
| |
| 基金项目： | 陕西省科技厅重点研发计划项目(2018SF-254)。 |
| |
| 摘 要： | 介绍2019年南非《利福平耐药结核病管理临床指南》的要点,包括耐药结核病治疗方案的制订、药品选择、特殊人群的治疗、密切接触者的管理等,并与我国《耐药结核病化学治疗指南(2019年)》对比,对于不同之处进行分析。
|
| 关 键 词： | 结核 抗多种药物性 方案评价 指南 对比研究 评论 |
| 收稿时间： | 2020-11-25 |
Interpretation of Clinical Guidelines for the management of Rifampicin-resistant Tuberculosis in South Africa(2019)and its comparison with Guidelines for Drug-resistant Tuberculosis Chemotherapy in China(2019) |
| |
| FENG Ying,REN Fei. Interpretation of Clinical Guidelines for the management of Rifampicin-resistant Tuberculosis in South Africa(2019)and its comparison with Guidelines for Drug-resistant Tuberculosis Chemotherapy in China(2019)[J]. The Journal of The Chinese Antituberculosis Association, 2021, 43(3): 295-298. DOI: 10.3969/j.issn.1000-6621.2021.03.018 |
| |
| Authors: | FENG Ying REN Fei |
| |
| Affiliation: | Department of Drug-resistant Tuberculosis, Xi’an Chest Hospital, Shaanxi 710100, China |
| |
| Abstract: | To interpret the Clinical Guidelines for the management of Rifampicin-resistant Tuberculosis in South Africa(2019),including how to choose drugs,formulate treatment regimens as well as how to treat special patients,manage close contacts;and then to compare this South Africa Guidelines with the Guidelines for Drug-resistant Tuberculosis Chemotherapy in China(2019). |
| |
| Keywords: | Tuberculosis multidrug-resistant Program evaluation Guidelines Comparative study Comment |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《中国防痨杂志》浏览原始摘要信息 |
|
点击此处可从《中国防痨杂志》下载全文 |
